PHENOLIC COMPOSITION, ANTI-BIOFILM, ANTI-QUORUM SENSING, ANTIOXIDANT AND ENZYME INHIBITORY ACTIVITIES OF PTELEOPSIS SUBEROSA (COMBRETACEAE) LEAVES
Alain Yaya Koudoro1, Alfred Ngenge Tamfu2-4*, Aristide Mfifen Munvera5, Selcuk Kucukaydin4, Pascal Agbangnan Dossa Cokou1, Félicien Avlessi1, Dominique Sohounhloue Codjo Koko1, Ozgur Ceylan3
|
|
ABSTRACT
P. suberosa is a multipurpose medicinal plant in West and Central Africa. Fourteen phenolic compounds were identified in the P. suberosa leaves extract using HPLC-DAD and gallic acid (175.10±0.42 µg/g) was the most abundant. The total phenolic content was 112.16 ± 0.33 mg GAE/g DW while the total flavonoid content was 36.10±0.58 mg QE/g DW. Minimal inhibitory concentration (MIC) values for antimicrobial activity were 0.3125 mg/mL and 1.25 mg/mL on S. aureus and E. faecalis respectively and 2.5 mg/mL and 0.3125 mg/mL on E. coli and S. typhi respectively. Biofilm inhibition evaluated at sub-MIC concentrations revealed that gram-negative biofilms were more susceptible to P. suberosa extract than gram-positive ones and E. coli biofilms were the most susceptible. The extract inhibited violacein production and quorum sensing with inhibition zones varying from 17.0±0.5 mm at MIC to 12.0±0.1 mm at MIC/4. The extract showed good antioxidant capacity and was more active in the DPPH• assay than the two standards α-tocopherol and BHA used. In the ABTS•+ and CUPRAC assays, the activity of the extract was greater than that of α-Tocopherol and very close to that of BHA. The extract showed potential to alleviate Alzheimer’s disease by inhibiting acetylcholinesterase and butyrylcholinesterase as well as antidiabetic activity by inhibiting α-amylase and α-glucosidase.
Keywords: P. suberosa, Phenolic composition, Antibiofilm, Quorum-sensing inhibition, Anticholinesterase, Antidiabetic
Introduction
Traditional medicine is highly used in several poor countries in the treatment of various ailments. Plants develop various means to protect themselves by the production of secondary metabolites of wide structure which makes them a suitable basis for drugs and about 60% of the drugs being approved come from natural products [1]. The use of plants as medicine to cure or prevent illness in the world and particularly in Africa is very important as there is a general lack of medical facilities and trained medical practitioners in addition to high cost, unaffordability, unavailability, and inaccessibility [2, 3]. It has globally been used as an important source of traditional medicine to treat diseases since antiquity and over half of the conventional drugs are developed or discovered from plant sources [4]. The emergence of pathogens resistant to antibiotics is increasingly high and represents a serious problem for public health [5]. Resistance to antibiotics usually arises when target bacteria come up with a physiological mechanism to challenge the effects of the drug usually by changing its envelope structure which is the biofilm or by producing chemical substances that overcome the drugs or evade it [6]. Bacteria form protective extracellular matrix called biofilms through a quorum sensing (QS) regulated communication system with autoinducer signal compounds which makes them less susceptible to antibiotics and stress stimuli [7]. A suitable strategy to overcome antibiotic resistance is to target activities of bacteria that are controlled by quorum-sensing and to inhibit the establishment of biofilms. Several antibiotics produced by the pharmacological industry are usually faced with resistance over time thereby giving room for the search for natural plant-based antibiotics. Reactive nitrogen and oxygen species (RNOS) formed from cellular activities or exposure to toxic substances and adverse conditions can oxidize biomacromolecules such as lipids, proteins, and DNA in living systems, leading to oxidative stress at the cellular level and destruction of biomolecules such as lipids, DNA and various proteins [8]. Oxidative damage results from the inequality of RNOS production and the system’s antioxidant defense mechanisms and this is at the origin of various pathological conditions. Natural antioxidants are gaining more interest, and phytochemicals are believed to be safer and more effective antioxidants. Enzymes are important in catalyzing biochemical reactions but their excessive activity can create unwanted conditions and lead to illnesses. Enzymes such as butyrylcholinesterase (BChE), acetylcholinesterase (AChE), tyrosinase, α-amylase, urease, and α-glucosidase are involved in pathogenesis in humans and their inhibition is an effective strategy in the management of related diseases [9, 10]. Medicinal plants and other natural products represent an immense resource, providing bioactive molecules which can act as enzyme inhibitors in the treatment of certain human diseases [11].
Pteleopsis suberosa (Combretaceae) Engl. and Diels is usually 6–10 m tall with characteristic coarse and corky warts on its barks and it is a deciduous shrub. The various parts of P. suberosa are used for medicinal purposes throughout West and Central Africa. Fresh root decoction of this plant is used as a remedy for dermatitis, enema, stomach ache, and gastric ulcers, as well as purgative and antidysentery. Its shoots and root extracts are consumed as an antitussive [12]. Infusions from barks or and twigs of P. suberosa are used in treating jaundice, hemorrhoids, toothache, filariasis, trachoma, wounds, conjunctivitis, cataract amoebic dysentery, antiulcer, skin disease, antiviral and as an aphrodisiac [12-14]. Phytochemical studies of this plant have revealed that it contains phenolics, tannins, coumarins, and triterpenoids as essential phytoconstituents [12, 13]. The different parts of P. suberosa possess anti-inflammatory, antifungal, and antioxidant activities [13, 14].
However, few reports exist about the medicinal uses of the leaf extract which is claimed by practitioners of natural medicine. This work aims at the valorization of Pteleopsis suberosa through the determination of its phenolic composition and its inhibitory potential of quorum-sensing processes, biofilm formation, and enzymes associated with some human ailments.
Plant Material and Extraction
Pteleopsis suberosa Engl. Diels leaves were collected in January 2019 in the central region of the Benin Republic. The plant identification was done by the botanist Prof. Hounnankpon YEDOMONHAN who prepared a voucher specimen YH 721/HNB and deposited it at the Benin National. The extraction was made with water: ethanol (30: 70) under ultrasonic conditions. Briefly, 5 g of leaves powder in extraction solvent (100 mL) was subjected to ultra-sound using a Bandelin (Sonorex Digitech device) bath at 50 ℃ for 2h. The supernatant was passed through filter paper (Whatman No.1) and evaporated using a rotary evaporator (Buchi R215) at 70 ℃ to afford a crude extract which was stored at 4 ℃ in the dark until characterization and assays.
Determination of Phenolic Profile Extract Using HPLC–DAD
RP-HPLC (reversed-phase) containing a diode-array-detector (DAD) was used to detect phenolics in the extract as described elsewhere [9, 15]. A known weight of the extract was added to H2O/MeOH (80/20) and a 0.25 μm disk filter was used in filtration before injection. 20.0 μL injection volume in C18 column (Intersil ODS-3) at a 1 mL/min solvent flow and eluents: 0.50% CH3COOH in H2O (A) and 0.50% acetic acid in MeOH (B) with variable elution gradient was used. The DAD detector was set at 280 nm. Authentic samples’ retention times and UV data were used for identification. Calibration plots using 0.0~1.0 ppm of twenty-six authentic samples (Gallic, Protocatechuic, Ellagic, p-Hydroxybenzoic, 3-Hydroxybenzoic, Chlorogenic, Syringic, trans-Cinnamic, Rosmarinic, Vanillic, p-Coumaric, Ferulic acids; then Catechin, Hesperetin, Luteolin, Apigenin, 6,7-Dihydroxycoumarin, Kaempferol, Pyrocatechol, Vanillin, Coumarin, Taxifolin, Myricetin, Rutin, Chrysin and Quercetin) were used. The detected compounds are reported as micrograms per gram of dry plant weight.
Evaluation of Total Flavonoid and Phenolic Contents of P. Suberosa Extract
The TPC (total phenolic content) of the P. suberosa extract was done using the reagent of Folin-Ciocalteu [16]. 0.20 mL of Folin-Ciocalteu in 0.60 mL of H2O was added to either gallic acid or P. suberosa extract (0.20 mL) and stirred for 5 min. 1.0 mL of NaHCO3 (8.0%) was introduced. H2O was added to make 3.0 mL total volume followed by half an hour incubation of the mixture in the dark, then centrifugation and absorbance at 765 nm. The standard gallic acid curve was established and TPC was calculated and expressed as GAE/gDW. TFC (total flavonoid content) was measured by the AlCl3 method [16]. Serial dilutions (5.0–400.0 𝜇g/mL) were made from quercetin or extract (5 mg in 1 mL MeOH). 0.60 mL test solutions and 0.60 mL of 2% AlCl3 were added, stirred, and incubated for 1 h. Absorbances were recorded against a blank at 420 nm. The TFC of P. suberosa extract was deduced from a calibration plot of the standard quercetin and given as mgQE/gDW.
Microorganisms
Biofilm and antibacterial assays (Enterococcus faecalis ATCC 29212, Escherichia coli ATCC 25922, Salmonella Typhi ATCC 14028, Staphylococcus aureus ATCC 25923); quorum-sensing and violacein (Chromobacterium violaceum CV026 and CV12472); swarming assay (Pseudomonas aeruginosa PA01).
Antimicrobial Assay (Minimal Inhibitory Concentration MIC)
MIC of P. suberosa extract was investigated using broth-dilution means as described elsewhere [17]. Mueller-Hinton broth and 96-well plates were used. 100.0 μL bacterial solutions (5×105 CFU/mL) in the presence/absence of P. suberosa extract (5.0 - 0.0781 mg/mL). Incubation of all microplates at 37 ºC for 24 hours was done and MIC values were deduced.
Biofilm Inhibitory Effect of P. Suberosa Extract
The effect of P. suberosa extract to inhibit biofilms at MIC and below MIC (sub-MIC) was evaluated using the microplate biofilm assay [17, 18]. Briefly, 200.0 μL of TSB (Tryptic-Soy-Broth) with 0.25% glucose and 1.0% of overnight cultures were incubated with or without P. suberosa extract at 37 ºC for 48 h. Control wells had no extract. Planktonic bacteria were removed gently and the biofilm was further stained with 200.0 μL per well of crystal violet (0.10% in H2O). After 30 mins, the wells were rinsed and filled with 200.0 μL of 70.0% ethanol or 33.0% acetic acid. The absorbances were read at 550 nm. The calculation of percentage biofilm inhibition is shown in Equation 1.
|
(1) |
Anti-Quorum Sensing Assay Against C. Violaceum CV026
Anti-QS effect was investigated as performed previously [18]. 100 µL of CV026 overnight cultures were added to 5.0 mL of warm soft-molten-agar (agar 1.30 g, 1.00 g sodium chloride, 2.00 g tryptone, 200.0 mL H2O) followed by 20 µL of exogenous hormone source of acyl-homoserine lactone (100 µg/mL). The mixture was poured gently over solidified sterile LBA plate. Wells with diameters of 5.0 mm were created and filled with P. suberosa extract (50.0 µL) at below MIC and MIC. Incubation of plates at 30°C for 3 days in upright positions was done. Diameters of cream-colored halos (QSI zones) of each well were recorded in millimeters.
Violacein Assay Against C. Violaceum CV12472
P. suberosa extract was evaluated qualitatively for its violacein inhibition [18]. To each well of a 96-well sterile plate were added 180.0 µL of LBA (Luria-Bertani-broth) and 0.40 optical density at 600 nm CV12472 (10.0 µL) overnight cultures with or without and 20.0 µL of P. suberosa extract at below-MIC and MIC. Control wells had no extract. Incubation of plates for 24 h at 30°C was followed by measurement of reduced violacein pigmentation at 585 nm. The violacein inhibition percentage was calculated using the formula in Equation 2 below.
×100 |
(2) |
Swarming Inhibition Against Pseudomonas Aeruginosa PA01
Anti-swarming was investigated as reported [18]. Briefly, unto swarm plates (1.0% peptone, 0.50% NaCl, 0.5% agar, 0.5% of filter-sterilized D-Glucose) centers containing P. suberosa extract (MIC, MIC/2, and MIC/4) was point-inoculated 5.0 µL of cultures of P. aeruginosa PA01. The control plates were without the extract. Incubation was done at 37°C for 1 day. Swarming migration fronts were measured and the percentage inhibition of swarming was calculated.
Antioxidant Assay
Lipid-peroxidation was done by the β-carotene-linoleic acid experiment [9, 18]. DPPH• and ABTS•+ activities were determined spectrophotometrically as described elsewhere [9, 18]. CUPRAC (Cupric-reducing antioxidant capacity) was evaluated as previously described [9]. Butylated hydroxyanisole (BHA) and α-Tocopherol served as standards in DPPH•, CUPRAC, ABTS•+, and lipid peroxidation assays. The Fe2+ metal chelating potential was evaluated spectrophotometrically with EDTA as standard [9, 15].
Anticholinesterase Assay
Butyrylcholinesterase (BChE) and acetylcholinesterase (AChE) inhibitions were investigated using the Ellman method [9, 15]. Horse serum source BChE and electric eel source AChE as enzymes and acetylthiocholine iodide and butyrylthiocholine chloride as substrates. DTNB (5,5′-Dithio-bis(2-nitrobenzoic) acid) was used to monitor the cholinesterase assay and Galantamine served as the reference compound.
Anti-Diabetic Assay
α-glucosidase inhibitory capacity was done as described previously [9]. α-amylase inhibition was investigated with starch-iodine means [9]. The enzymes α-glucosidase (Saccharomyces cerevisiae) and α-amylase (porcine pancreas) were used. Acarbose served as a reference. Results were expressed as 50% inhibition concentration (IC50) and percent inhibition at 100 µg/mL.
Urease Inhibition Assay
Indophenol assay was used to evaluate urease inhibition activity [9, 15]. A solution of urease from a Jack bean source (Type III) in sodium-phosphate buffer (100.0 mM, pH 8.20) was prepared. A mixture containing 10.0 µL test sample, 50.0 µL of urea (100.0 mM), and 25.0 µL urease was incubated at 30 °C for 15 mins. After incubation, 70.0 μL of 0.0050% (w/v) alkali reagent and 45.0 μL of 1.0% (w/v) phenol reagent were introduced and further incubated for 50 mins. Thiourea was the reference compound and absorbances were taken at 630 nm. Percent inhibitions at 100 µg/mL and 50% inhibitory concentration (IC50) were reported.
Tyrosinase Inhibitory Assay
The anti-tyrosinase effect was investigated spectrophotometrically as described elsewhere [9, 15]. Briefly, 20.0 μL of mushroom source tyrosinase, 10.0 μL extract, and 150.0 μL sodium-phosphate buffer (100.0 mM, pH 6.80) were mixed. Incubation for 15 mins at 37°C was done. 20.0 μL substrate L-DOPA was introduced and absorbances at 475 nm were taken after 10 mins incubation. Kojic acid served as a reference compound. Percent inhibitions at 100 µg/mL and 50% inhibitory concentration (IC50) were reported.
Results and Discussion
Water-ethanol mixture is a non-toxic solvent suitable for the extraction of nutraceuticals that are rich in phenolic compounds. The phenolic composition, antimicrobial, antibiofilm, anti-quorum sensing, antioxidant, anti-urease, anticholinesterase, antidiabetic and anti-tyrosinase activities of the hydro-ethanol extract of P. suberosa leaves are reported below.
Phenolic Composition
The following phenolic compounds were detected in the extract of P. suberosa using HPLC-DAD and reported in Table 1 and the chromatograms for the analysis are provided in Figure 1.
Table 1. HPLC-DAD phenolic composition of P. suberosa extract by (µg/g)a
RT (min) |
Phenolic compounds |
Content |
5.70 |
Gallic acid |
175.10±0.42 |
8.75 |
Protocatechuic acid |
2.25±0.08 |
11.04 |
Pyrocatechol |
8.71±0.14 |
12.35 |
Chlorogenic acid |
4.65±0.05 |
15.09 |
Caffeic acid |
6.20±0.17 |
20.56 |
p-Coumaric acid |
7.83±0.21 |
22.14 |
Ferulic acid |
9.90±0.13 |
24.49 |
Coumarin |
13.54±0.36 |
25.30 |
Rutin |
7.44±0.24 |
26.77 |
Rosmarinic acid |
10.67±0.20 |
27.35 |
Myricetin |
15.57±0.18 |
31.33 |
trans-Cinnamic acid |
4.50±0.09 |
31.70 |
Luteolin |
4.74±0.20 |
38.40 |
Chrysin |
48.20±0.51 |
aValues are means ± S.E.M. (p < 0.05).
Gallic acid, protocatechuic acid, pyrocatechol, chlorogenic acid, p-coumaric acid, caffeic acid, coumarin, ferulic acid, rutin, rosmarinic acid, myricetin, trans-cinnamic acid, luteolin, and chrysin were identified in the extract and their structures are given on Figure 2. Gallic acid (175.10±0.42 µg/g) was the most abundant compound amongst the detected phenolic compounds. Spectrophotometric methods were used to quantify the total phenolics and flavonoids in the extract. TPC detected using the Folin-Ciocalteu reagent was 112.16 ± 0.33 mg GAE/g DW while TFC detected using the AlCl3 reagent was 36.10± 0.58 mg QE/g DW.
|
a) |
|
b) |
Figure 1. HPLC chromatograms; a) Standards, b) Extract of P. Suberosa |
|
Figure 2. Structures of detected phenolic compounds in P. Suberosa extract |
Antimicrobial and Anti-Biofilm Activities
The phenolic-rich extract of P. suberosa exhibited antibacterial effects on two gram-positive and gram-negative bacteria and the minimal inhibitory concentrations are given in Table 2. On the gram-positive bacteria, the MIC values were 0.3125 mg/mL and 1.25 mg/mL on S. aureus and E. faecalis respectively while on gram-negative bacteria, MIC values were 2.5 mg/mL and 0.3125 mg/mL on E. coli and S. typhi respectively. Biofilm inhibition was evaluated on these bacteria at below MIC and MIC and provided in Table 2. For the gram-positive bacteria, the biofilm inhibition varied from 37.57±0.63% (MIC) to 8.02±0.08% (MIC/4) against S. aureus and from 48.46±0.72% (MIC) to 10.1±0.13 (1/4 MIC). As concerns the gram-negative bacteria, the biofilm inhibitions varied from 86.35±2.02% (MIC) to 29.1±0.35% (1/8 MIC) against E. coli and from 54.36±0.82% (MIC) to 15.48±0.21% (1/4 MIC) against S. typhi. It can be observed that gram-negative biofilms were more susceptible to P. suberosa extract with E. coli biofilms being the most susceptible.
Table 2. Antibiofilm (%inh.) and antimicrobial (MIC) activities of P. suberosa extract
Microorganism |
mg/mL |
|
S. aureus |
0.3125 |
|
E. faecalis |
1.2500 |
|
E. coli |
2.5000 |
|
S. typhi |
0.3125 |
|
Biofilm percentage inhibition (%) |
||
S. aureus |
MIC |
37.57±0.63 |
1/2 MIC |
19.94±0.25 |
|
1/4 MIC |
8.02±0.08 |
|
1/8 MIC |
- |
|
E. faecalis |
MIC |
48.46±0.72 |
1/2 MIC |
28.34±0.39 |
|
1/4 MIC |
10.1±0.13 |
|
1/8 MIC |
- |
|
E. coli |
MIC |
86.35±2.02 |
1/2 MIC |
68.74±1.62 |
|
1/4 MIC |
46.06±1.12 |
|
1/8 MIC |
29.1±0.35 |
|
S. typhi |
MIC |
54.36±0.82 |
1/2 MIC |
35.27±0.43 |
|
1/4 MIC |
15.48±0.21 |
|
1/8 MIC |
- |
-: No inhibition
Violacein, Quorum-Sensing, and Swarming Inhibition Activities
Quorum sensing inhibition was measured at below MIC and MIC against two chromo-bacteria and reported in Table 3. The MICs of P. suberosa were found to be 0.625 mg/mL and 0.25 mg/mL against C. violaceum CV026 and C. violaceum CV12472 respectively. Violacein inhibition on CV12472 varied from 100% (MIC) to 12.0±0.4% (1/8 MIC) while anti-QS zones of inhibition ranged from 17.0±0.5 mm at MIC to 12.0±0.1 mm at 1/4 MIC. Swarm motility inhibition was evaluated against P. aeruginosa PA01 at below MIC and MIC and reported in Table 3. The MIC value of P. suberosa extract on P. aeruginosa PA01 was found to be 2.5 mg/mL. The percent of inhibition ranged from 75.8±1.2% at MIC to 32.6±0.5% at 1/4 MIC.
Table 3. Violacein, quorum-sensing and swarming inhibitions by P. suberosa extract
MIC value (mg/mL) |
% inhibition of violacein against C. violaceum CV12472 |
||||
MIC |
1/2 MIC |
1/4 MIC |
1/8 MIC |
1/16 MIC |
|
0.25 |
100.0±0.0 |
58.5±1.8 |
23.4±0.7 |
12.0±0.4 |
- |
|
Diameters (mm) of quorum-sensing inhibition against C. violaceum CV026 |
||||
0.625 |
17.0±0.5 |
15.0±1.1 |
12.0±0.1 |
- |
- |
|
% inhibition of swarming motility against P. aeruginosa PA01 |
||||
2.5 |
75.8±1.2 |
50.1±0.4 |
32.6±0.5 |
- |
- |
-: No inhibition
Antioxidant Activity
P. suberosa extract showed good antioxidant activity evaluated through five complementary assays as shown in Table 4. Since its IC50 value was 21.96±0.56 µg/mL, the extract is more active in the DPPH• assay than used. In the CUPRAC and ABTS•+ assays, the activity of the extract was greater than that of α-Tocopherol and very close to that of BHA standard antioxidants. However, the extract was less active than the standards in both lipid peroxidation and chelating assays but its activity remained relatively good compared to that of the standards.
Table 4. Antioxidant activity of P. suberosa extract (IC50 in µg/mL)
Sample |
β-Carotene-linoleic acid assay |
DPPH• assay |
ABTS•+ assay |
CUPRAC assay |
Metal chelating assay |
Extract |
15.80±0.71 |
21.96±0.56 |
14.24±0.78 |
35.48±0.60 |
41.25±0.90 |
α-Tocopherol |
2.10±0.07 |
38.15±0.50 |
35.50±0.56 |
60.25±0.55 |
NDb |
BHA |
1.45±0.03 |
19.75±0.33 |
12.80±0.08 |
25.40±0.40 |
NDb |
EDTA |
NDb |
NDb |
NDb |
NDb |
5.52±0.35 |
a Values are means ± SEM (p < 0.05). c ND: not determined.
Enzyme Inhibitory Activities
The extract of P. suberosa inhibited some key enzymes that interfere with human illnesses as given in Table 5. BChE and AChE were inhibited by the extract of P. suberosa, but BChE exhibited an IC50 of 55.17±0.83 µg/mL compared to 42.20±0.48 µg/mL for galantamine used as the standard drug. Carbohydrate digestive enzymes were also inhibited by P. suberosa extract showing IC50 values of 50.63±0.58 µg/mL compared to 20.52±0.84 µg/mL for acarbose on α-glucosidase and IC50 value of 81.37±0.92 µg/mL compared to the standard acarbose with IC50 value of 32.57±0.78 µg/mL on α-amylase. The extract equally inhibited urease (38.76±0.35%) and tyrosinase (30.52±0.80%) at 100 µg/mL.
Table 5. Cholinesterase, urease, α-glucosidase, α-amylase and tyrosinase inhibitory activities of P. suberosa extract
|
Anti-cholinesterase activity |
Anti-diabetic activity |
|
|
||||||||
AChE |
BChE |
α-glucosidase |
α-amylase |
urease inhibition activity |
Tyrosinase inhibition activity |
|||||||
Sample |
Inh. (%) |
IC50 |
Inh. (%) |
IC50 |
Inh. (%) |
IC50 |
Inh. (%) |
IC50 |
Inh. (%) |
IC50 |
Inh. (%) |
IC50 |
Extract |
36.50±0.75 |
>100 |
66.25±0.54 |
55.17±0.83 |
70.85±0.91 |
50.63±0.58 |
55.72±0.69 |
81.37±0.92 |
38.76±0.35 |
>100 |
30.52±0.80 |
>100 |
Galantamine |
85.50±0.57 |
5.50±0.25 |
74.65±0.21 |
42.20±0.48 |
NIL |
NIL |
NIL |
NIL |
NIL |
NIL |
NIL |
NIL |
Acarbose |
NIL |
NIL |
NIL |
NIL |
82.40±0.70 |
20.52±0.84 |
77.59±1.10 |
32.57±0.78 |
NIL |
NIL |
NIL |
NIL |
Thiourea |
NIL |
NIL |
NIL |
NIL |
NIL |
NIL |
NIL |
NIL |
83.80±0.60 |
8.20±0.35 |
NIL |
NIL |
Kojic acid |
NIL |
NIL |
NIL |
NIL |
NIL |
NIL |
NIL |
NIL |
NIL |
NIL |
79.50±0.32 |
23.75±0.30 |
Values are means ± SEM (p < 0.05). NIL: not determined.
Leaves of P. suberosa contain bioactive phenolics and our results corroborate with some studies which characterized phenolic compounds and flavonoids in the extracts of the leaves of this plant, easily extractable with alcohol [19, 20]. However, the TPC and TFC determined in this study were lower compared to those reported for a hydro-alcoholic extract of this plant but water-ethanol solvent represents a suitable extraction solvent for a phenol-rich bioactive extract of this plant [21]. Phenolic compounds and plant extracts which are rich in them possess numerous health and nutritional benefits and continue to attract research in this domain [22-25]. This plant contains several phenolic glycosides as well, notably those with myricetin, kaempferol, and quercetin as aglycones. Phenolic-rich extracts can be exploited for antioxidant, antimicrobial, and enzyme inhibition potentials.
In this study, the extract of P. suberosa has shown good antibacterial activity. One study, which supports our findings here, indicates antibacterial effects of P. suberosa exhibited against Gram-negative and Gram-positive bacteria which ascertains its use in traditional medicine [26, 27]. Despite the antimicrobial potential of this plant, its effect on bacterial biofilms has not been evaluated previously. In this study, the extract reduced formation of biofilms by various bacteria. Biofilms are the root causes of recalcitrant chronic infectious diseases and are made up of colonies of bacteria on both abiotic and biotic surfaces covered with dense protective polymeric matrix requiring large amounts of antibiotics, almost 10 to 1000 more times to be able to kill the microbes beneath [28, 29]. Most infectious diseases and microbial resistance results from bacterial biofilm formation and this causes a serious problem in food and medical materials since biofilms create reduced penetration of antibiotics into bacterial communities, making biofilm colonies resistant to host-immune defense and antibiotics, creating persistency of infections [30-32]. It is, therefore, necessary to search for new natural treatments which may eliminate biofilm establishment and break quorum-sensing networks to decrease any development of bacterial resistance to existing antibiotics. The results of antimicrobial activity and antibiofilm potential indicate that P. suberosa extract can be used to inhibit bacterial growth as well as at low doses to reduce the formation of bacterial biofilms over time.
Quorum sensing consists of a cell-cell communication network within bacterial communities that involves the production, reception, and dissemination of signal compounds that help the microbes to survey their environmental conditions and population to be able to carry out their activities coordinatively and in synergy [33, 34]. Violacein pigment protects the bacteria from oxidative damage and it constitutes a simple and measurable form of signal molecule emission whose inhibition represents an anti-QS effect in bacteria [35, 36]. The fact that the extract inhibited violacein formation indicates that it can prevent the production of signal molecules that will help to promote bacteria coordination. The extract also inhibits QS in C. violaceum CV026 despite the AHL supplied to it and this indicates that extracts can disrupt signal reception. The quorum sensing inhibition zones corresponds to the clear halo on the violet lawn and the diameters of those zones were measured in millimeters.
Quorum-sensing breakage is a good strategy to overcome the spread of infection as well as their severity and also aids in the reduction of resistance to antibiotics, and new antimicrobial materials that fall in this domain are being increasingly studied [37-39]. Swarming movement is a phenomenon that precedes biofilm formation since it enables bacteria to get onto surfaces and subsequently colonize them [23, 36, 40]. The extract inhibited swarming movement in the flagellated P. aeruginosa PA01 and therefore, can aid in reducing the spread of bacteria through surfaces and biofilms as well.
The extract showed to contain reasonable amounts of flavonoids and phenolics and these compounds possess antioxidant activities. The fact that the extracts had a good antimicrobial and antioxidant activity which could be conferred by the phenolics contained in the extract [41]. The results of this research are in agreement with reported data on the antioxidant activity of P. suberosa [13, 42]. The hydro-ethanolic leave extract of P. suberosa has been shown to possess antioxidant activity attributable to the total flavonoids and total phenolic compounds they contain [43].
The enzymes AChE and BChE contribute to Alzheimer’s disease, α-amylase and α-glucosidase hydrolyze starch into glucose and cause hyperglycemia and diabetes, and urease plays a role in the development of stomach ulcerations involving Helicobacter pylori while tyrosinase causes browning of fruits and skin pigmentation issues in animals. All of the effects above are undesirable to human health and therefore inhibitors of such enzymes especially from natural sources have been described as a suitable means of promoting human health [9, 24]. The plant extract was able to inhibit both cholinesterases (AChE and BChE) and cholinesterase inhibitors are known to help in boosting cholinergic deficit and maintaining good levels of acetylcholine for the prevention and Alzheimer’s disease. The phenolic compounds present in this extract as well as other possible classes of compounds can contribute to the cholinesterase activity since phenolic units are one of the suitable natural cholinesterase inhibitors [44-46]. α-glucosidase and α-amylase break down carbohydrates and this leads to an increase in blood glucose levels therefore the inhibition of these enzymes reduces the risk of the development of diabetes [32, 47-49]. This plant has exhibited good antidiabetic potential by inhibiting both α-amylase and α-glucosidase. Our findings are in line with some studies which report that P. suberosa is used traditionally to remedy type-II diabetes and can inhibit carbohydrate enzymes and alleviate induced diabetes in animal model studies [20, 42]. Natural antidiabetic extracts and compounds are being developed and find applications in traditional medicines and are considered cheaper, safer, and more effective [10, 49, 50].
Conclusion
Pteleopsis suberosa is a major plant used in complementary medicine in West and Central Africa. The phenolic extract was prepared from the leaves of this plant using an ultrasonic device with a hydro-alcoholic solution as solvent. The TPC and TFC of P. suberosa leave extract were measured and reported while HPLC-DAD was used to establish the phenolic profile using twenty-six standard compounds. Gallic acid was the most abundant out of the fourteen phenolic compounds detected by HPLC-DAD. The extract showed good antimicrobial activity as well as antibiofilm activity at sub-MIC. QS was inhibited in C. violaceum CV026 as well as inhibition of production of the pigment, violacein was exhibited against C. violaceum CV12472. The results of antimicrobial studies indicate that the P. suberosa extract can slow down the emergence of bacterial resistance. The plant showed potential in reducing oxidative stress and it exhibited antioxidant potential in five complementary assays. The extract inhibited some key enzymes that interfere with human diseases including BChE, AChE, urease, α-glucosidase, tyrosinase, and α-amylase. The findings of this research ascertain the medicinal potential of this plant and its safe use in traditional medicine.
Acknowledgments: The authors are grateful to Mugla Sitki Kocman University, the University of Ngaoundere, and the University of Abomey-Calavi for material support. Also, the International Center for Genetic Engineering and Biotechnology (ICGEB) is greatly acknowledged.
Conflict of interest: None
Financial support: None
Ethics statement: None
1. Castro C. Editorial: Natural plant antioxidants and cardiovascular disease. Front Physiol. 2022;13:848497. doi:10.3389/fphys.2022.848497
2. Shahid I, Khan KM, Khan TM, Imran MS, Shahid N, Alnafoosi FN, et al. Clinical Efficacy of LivPro® Herbal Medicine among Hepatitis C Patients Pakistan: Longitudinal Interventional Study. Arch Pharm Pract. 2021;12(4):54-7.
3. Ismail RWK, Turkistani H, Alharthi R, Kariri AM, Khan A. The Extend and Reasons behind the Use of Herbal Medicine as an Alternative Treatment in Dentistry. Arch Pharm Pract. 2021;12(1):135-40.
4. Krylova O, Rozhnova S, Tananakina G, Marievskii V, Magomedova Z, Magomedova R. Analysis of the retail range of antifungal medicines using an integrated ABC-XYZ analysis matrix. J Adv Pharm Educ Res. 2021;11(2):106-12.
5. Lagnika L, Fantodji MHT, Sanni A. Phytochemical study and antibacterial, antifungal and antioxidant properties of Bridelia ferruginea and Pteleopsis suberosa. Int J Pharm Sci Res. 2012;3(7):2130-6.
6. Aljeldah MM. Antimicrobial resistance and its spread is a global threat. Antibiotics. 2022;11(8):1082. doi:10.3390/antibiotics11081082
7. Sionov RV, Steinberg D. Targeting the holy triangle of quorum sensing, biofilm formation, and antibiotic resistance in pathogenic bacteria. Microorganisms. 2022;10(6):1239. doi:10.3390/microorganisms10061239
8. Tanabe S, O'Brien J, Tollefsen KE, Kim Y, Chauhan V, Yauk C, et al. Reactive oxygen species in the adverse outcome pathway framework: toward the creation of harmonized consensus key events. Front Toxicol. 2022;4:887135. doi:10.3389/ftox.2022.887135
9. Küçükaydın S, Çayan F, Tel-Çayan G, Duru ME. HPLC-DAD phytochemical profiles of Thymus cariensis and T. cilicicus with antioxidant, cytotoxic, anticholinesterase, anti-urease, anti-tyrosinase, and antidiabetic activities. South Afric J Bot. 2021;143:155-63. doi:10.1016/j.sajb.2021.07.018
10. Tchuente Djoko C, Gade IS, Atchade ADT, Tamfu AN, Mihaela Dinica R, Sangu E, et al. An a-Sophoradiol glycoside from the root wood of Erythrina senegalensis DC. (Fabaceae) with α-amylase and α-glucosidase inhibitory potential. Nat Prod Com. 2021;16(9):1-6.
11. Metiefeng NT, Tamfu AN, Fotsing Tagatsing M, Tabopda TK, Kucukaydin S, Noah Mbane M, et al. In Vitro and in Silico Evaluation of Anticholinesterase and Antidiabetic Effects of Furanolabdanes and Other Constituents from Graptophyllum pictum (Linn.) Griffith. Molecules. 2023;28(12):4802.
12. Akintunde JK, Babaita AK. Effect of PUFAs from Pteleopsis suberosa stems bark on androgenic enzymes, cellular ATP and prostatic acid phosphatase in mercury chloride – exposed rat. Mid East Fert Soc J. 2017;22(3):211-8.
13. Germanò MP, D'Angelo V, Biasini T, Miano TC, Braca A, De Leo M, et al. Anti-ulcer, anti-inflammatory and antioxidant activities of the n-butanol fraction from Pteleopsis suberosa stem bark. J Ethnopharmacol. 2008;115(2):271-5. doi:10.1016/j.jep.2007.10.001
14. Baba-Moussa F, Akpagana K, Bouchet P. Antifungal activities of seven West African Combretaceae used in traditional medicine. J Ethnopharmacol. 1999;66(3):335-8.
15. Tamfu AN, Kucukaydin S, Ceylan O, Sarac N, Duru ME. Phenolic composition enzyme inhibitory and anti-quorum sensing activities of cinnamon (Cinnamomum zeylanicum Blume) and Basil (Ocimum basilicum Linn). Chem Afric. 2021;4(4):759-67.
16. Chandra S, Khan S, Avula B, Lata H, Yang MH, Elsohly MA, et al. Assessment of total phenolic and flavonoid content antioxidant properties and yield of aeroponically and conventionally grown leafy vegetables and fruit crops: a comparative study. Evid Based Complement Alternat Med. 2014;253875. doi:10.1155/2014/253875
17. Ngenge TA, Ceylan O, Fru G, Arab Y, Emin ED, Ozturk M. Antimicrobial antibiofilm anti-quorum sensing and motility inhibition activities of essential oil from seeds of food spice Xylopia aethiopica (Dunal) A. Rich. on some pathogenic bacteria. Res J Biotechnol. 2021;16:68-76.
18. Tamfu AN, Ceylan O, Fru GC, Ozturk M, Duru ME, Shaheen F. Antibiofilm antiquorum sensing and antioxidant activity of secondary metabolites from seeds of Annona senegalensis Persoon. Mic Pathogen. 2020;144:104191.
19. De Leo M, Braca A, Sanogo R, Cardile V, DeTommasi N, Russo A. Antiproliferative activity of Pteleopsis suberosa leaf extract and its flavonoid components in human prostate carcinoma cells. Planta Med. 2006;72(7):604-10. doi:10.1055/s-2006-931556
20. Semporé JN, Diao M, Ouattara L, Ouoba P, Kagambega W, Sama H, et al. Potential antidiabetic effects of extracts from four medicinal plants used in Burkina Faso by inhibition of alpha-amylase. Diabetology. 2021;2(4):250-8. doi:10.3390/diabetology2040023
21. Klotoe JR, Fanou BA, Agbodjento E, Houehou A, Fah L, Dougnon V, et al. Antifungal activity of Ocimum gratissimum L. Lantana camara L. & Pteleopsis suberosa Engl. & Dies used in the treatment of vulvovaginal candidiasis in Benin. Futur J Pharm Sci. 2021;7:237. doi:10.1186/s43094-021-00383-4
22. Tamfu AN, Ceylan O, Kucukaydin S, Duru ME. HPLC-DAD phenolic profiles antibiofilm anti-quorum sensing and enzyme inhibitory potentials of Camellia sinensis (L.) O. Kuntze and Curcuma longa L. LWT - Food Sci Technol. 2020;133:110150.
23. Tamfu AN, Kucukaydin S, Quradha MM, Ceylan O, Ugur A, Duru ME. Ultrasound-assisted extraction of Syringa vulgaris Mill. Citrus sinensis L. and Hypericum perforatum L.: phenolic composition enzyme inhibition and anti-quorum sensing activities. Chem Afric. 2022;5(2):237-49.
24. Tamfu AN, Roland N, Mfifen AM, Kucukaydin S, Gaye M, Botezatu AV, et al. Phenolic composition antioxidant and enzyme inhibitory activities of Parkia biglobosa (Jacq.) Benth. Tithonia diversifolia (Hemsl) A. Gray and Crossopteryx febrifuga (Afzel.) Benth. Arabian J Chem. 2022;15(4):103675.
25. Mikwangock HD, Tamfu AN, Amang AP, Siwe GT, Mezui C, Kucukaydin S, et al. Chronic Gastric Ulcer Healing Actions of the Aqueous Extracts of Staple Plant Foods of the North-West Adamawa and West Regions of Cameroon. BioMed Res Int. 2023;2023. doi:10.1155/2023/2657278
26. Alain KY, Tamfu AN, Kucukaydin S, Ceylan O, Pascal AD, Félicien A, et al. Phenolic profiles antioxidant antiquorum sensing antibiofilm and enzyme inhibitory activities of selected Acacia species collected from Benin. LWT. 2022;171:114162. doi:10.1016/j.lwt.2022.114162
27. Sanogo R, Haïdara M, Dénou A. Improved traditional medicine for infectious disorders in Mali. InMedicinal Plants as Anti-Infectives 2022 Jan 1 (pp. 479-499). Academic Press. doi:10.1016/B978-0-323-90999-0.00004-5
28. Tamfu AN, Ceylan O, Kucukaydin S, Ozturk M, Duru ME, Dinica RM. Antibiofilm and enzyme inhibitory potentials of two annonaceous food spices African pepper (Xylopia aethiopica) and African nutmeg (Monodora myristica). Foods. 2020;9(12):1768.
29. Tamfu AN, Ceylan O, Cârâc G, Talla E, Dinica RM. Antibiofilm and anti-quorum sensing potential of cyclobutane-type triterpene acids from Cameroonian grassland propolis: phenolic profile and antioxidant activity of the crude extract. Molecules. 2022;27(15):4872.
30. Ikome HN, Tamfu AN, Abdou JP, Fouotsa H, Nangmo PK, Weyepe Lah FC, et al. Disruption of Biofilm Formation and Quorum Sensing in Pathogenic Bacteria by Compounds from Zanthoxylum Gilletti (De Wild) P.G. Waterman. Appl Biochem Biotechnol. 2023:1-9. doi:10.1007/s12010-023-04380-6
31. Singh A, Amod A, Pandey P, Bose P, Pingali MS, Shivalkar S, et al. Bacterial biofilm infections their resistance to antibiotics therapy and current treatment strategies. Biomed Mater. 2022;17(2):022003. doi:10.1088/1748-605X/ac50f6
32. Tamfu AN, Munvera AM, Botezatu AVD, Talla E, Ceylan O, Fotsing MT, et al. Synthesis of benzoyl esters of β-amyrin and lupeol and evaluation of their antibiofilm and antidiabetic activities. Res Chem. 2022;4:100322.
33. Mukherjee S, Bassler BL. Bacterial quorum sensing in complex and dynamically changing environments. Nat Rev Microbiol. 2019;17(6):371-82.
34. Boudiba S, Tamfu AN, Berka B, Hanini K, Hioun S, Allaf K, et al. Anti-quorum sensing and antioxidant activity of essential oils extracted from Juniperus species growing spontaneously in Tebessa Region (East of Algeria). Nat Prod Com. 2021;16(6):1-11.
35. Alfred TN, Ceylan O, Kucukaydin S, Olmez OT, Godloves CF, Sylvain SK, et al. HPLC-DAD and GC-MS characterization of Cameroonian honey samples and evaluation of their antibiofilm anti-quorum sensing and antioxidant activities. Bull Env Pharmacol Life Sci. 2020;9(10):132-42.
36. Alfred Ngenge T, Kucukaydin S, Ceylan O, Duru ME. Evaluation of enzyme inhibition and anti-quorum sensing potentials of Melaleuca alternifolia and Citrus sinensis essential oils. Nat Prod Com. 2021;16(9):1-8. doi:10.1177/1934578X211044565
37. Beddiar H, Boudiba S, Benahmed M, Tamfu AN, Ceylan Ö, Hanini K, et al. Chemical composition anti-quorum sensing enzyme inhibitory and antioxidant properties of phenolic extracts of Clinopodium nepeta L. Kuntze. Plants. 2021;10(9):1955.
38. Kocak G, Tamfu AN, Bütün V, Ceylan O. Synthesis of quaternary piperazine methacrylate homopolymers and their antibiofilm and anti-quorum sensing effects on pathogenic bacteria. J Appl Polym Sci. 2021;138(21):1-14.
39. Popova M, Gerginova D, Trusheva B, Simova S, Tamfu AN, Ceylan O, et al. A preliminary study of chemical profiles of honey cerumen and propolis of the African stingless bee Meliponula ferruginea. Foods. 2021;10(5):997.
40. Tamfu AN, Kocak G, Ceylan O, Citak F, Bütün V, Çiçek H. Synthesis of cross-linked diazaborine-based polymeric microparticles with antiquorum sensing anti-swarming antimicrobial and anti-biofilm properties. J Appl Polym Sci. 2023;140(11)e53631. doi:10.1002/app.53631
41. Egbujor MC, Okoro UC, Okafor S, Nwankwo NE. Synthesis characterization and in silico studies of novel alkanoylated 4-methyl phenyl sulphonamoyl carboxylic acids as potential antimicrobial and antioxidant agents. Int J Pharm Phytopharmacol Res. 2019;9(3):89-97.
42. Ceylan O, Tamfu AN, Doğaç Yİ, Teke M. Antibiofilm and anti-quorum sensing activities of polyethylene imine coated magnetite and nickel ferrite nanoparticles. 3 Biotech. 2020;10(12):513. doi:10.1007/s13205-020-02509-6
43. Aladodo AR, Sabiu S, Sulyman AO. Pteleopsis suberosa Engl. and Diels (Combretaceae) aqueous stem bark extract extenuates oxidative damage in streptozotocin-induced diabetic Wistar rats. Pharmacol J. 2019;11(1):183-90.
44. Tokoudagba KJMD, Gbaguidi FA. Phytochemical study and evaluation of the antioxidant activity of two medicinal plants in Benin. World J Pharm Res. 2021;11(1):94-103. doi:10.20959/wjpr20221-22520
45. Munvera AM, Alfred Ngenge T, Ouahouo BM, Kucukaydin S, Nyemb JN, Fokam Mafo MA, et al. Cholinesterase α-glucosidase tyrosinase and urease inhibitory activities of compounds from fruits of Rinorea oblongifolia CH Wright (Violaceae). Nat Prod Res. 2023:1-2. doi:10.1080/14786419.2023.2176491
46. Tamfu AN, Kucukaydin S, Yeskaliyeva B, Ozturk M, Dinica RM. Non-alkaloid cholinesterase inhibitory compounds from natural sources. Molecules. 2021;26(18):5582.
47. Arab Y, Sahin B, Ceylan O, Zellagui A, Olmez OT, Kucukaydin S, et al. Assessment of in vitro activities and chemical profiling of Senecio hoggariensis growing in Algerian Sahara. Biodiversitas. 2022;23(7):3498-506.
48. Feunaing RT, Tamfu AN, Gbaweng AJ, Mekontso Magnibou L, Ntchapda F, Henoumont C, et al. In Vitro Evaluation of α-amylase and α-glucosidase Inhibition of 2 3-Epoxyprocyanidin C1 and Other Constituents from Pterocarpus erinaceus Poir. Molecules. 2023;28(1):126. doi:10.3390/molecules28010126
49. Khan SN, Shaheen F, Aleem U, Sheikh S, Tamfu AN, Ashraf S, et al. Peptide conjugates of 18β-glycyrrhetinic acid as potent inhibitors of α-glucosidase and AGEs-induced oxidation. Eur J Pharm Sci. 2022;168:106045. doi:10.1016/j.ejps.2021.106045
50. Feunaing RT, Tamfu AN, Ntchapda F, Gade IS, Mbane MN, Tagatsing MF, et al. A new abietane-type diterpenoid from roots of Burkea africana Hook (Fabaceae) with α-amylase inhibitory potential. Nat Prod Res. 2021;20:1-8.